SCHEMBL735830

SCHEMBL735830

O=C(NCCc1c[nH]c2ccccc12)NCc1ccccc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.72
MEN1 O00255 6/20 0.72
MC4R P32245 1/20 0.69
NPC1 O15118 1/20 0.67
RAB9A P51151 1/20 0.67
TSHR P16473 2/20 0.67
LMNA P02545 2/20 0.67
CYP1A2 P05177 1/20 0.67
PKM P14618 1/20 0.67
CYP2C19 P33261 1/20 0.67
BLM P54132 1/20 0.67
MAPT P10636 4/20 0.65
ALDH1A1 P00352 2/20 0.65
KDM4E B2RXH2 1/20 0.65
CYP3A4 P08684 1/20 0.65
ALOX15 P16050 1/20 0.65
MAPK1 P28482 1/20 0.65
HSD17B10 Q99714 1/20 0.65
TDP1 Q9NUW8 1/20 0.65
MMP9 P14780 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6077115 0.88 TRPV1 (0.75) LMNACYP1A2BLMMAPTALDH1A1
SCHEMBL174362 0.85 MEN1 (0.72) KMT2AMEN1NPC1RAB9ATSHR
SCHEMBL6394942 0.84 MEN1 (0.76) KMT2AMEN1NPC1RAB9ATSHR
SCHEMBL12655245 0.84 GOT1 (0.72) KMT2AMEN1NPC1RAB9ATSHR
SCHEMBL734585 0.84 MEN1 (1.00) KMT2AMEN1NPC1RAB9ALMNA
SCHEMBL9118459 0.84 AANAT (0.71) KMT2AMEN1NPC1RAB9ATSHR
SCHEMBL9117842 0.83 MEN1 (0.76) KMT2AMEN1NPC1RAB9ATSHR
SCHEMBL7838803 0.82 LMNA (0.76) KMT2AMEN1MC4RLMNAMAPT
SCHEMBL28674791 0.82 PTGS2 (0.72) KMT2AMEN1NPC1RAB9A
SCHEMBL10069200 0.82 AANAT (0.77) KMT2AMEN1NPC1RAB9ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101516844-B 4-heteroaryl substituted 1-aminocyclohexane-1-and cyclohexene-1-derivatives having activity on opioid receptor systems GRUENENTHAL GMBH 2013-12-11 CN disclosed
US-8138187-B2 Substituted heteroaryl derivatives GRUENENTHAL GMBH (DE) 2012-03-20 US disclosed
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES GRUNENTHAL GMBH (DE) 2010-01-14 US disclosed
CN-101516844-A 4-heteroaryl substituted 1-aminocyclohexane-1-and cyclohexene-1-derivatives having activity on opioid receptor systems GRUENENTHAL GMBH (DE) 2009-08-26 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES CYP3A43, HMGCR, ABCG2 KMT2A 2453/4885MEN1 2253/4885MC4R 1587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.